Sort
39,280 grants matching “leukemia”
The role of reorganization energy in achieving selective kinase inhibition
$352,465John Damon Chodera · Sloan-Kettering Inst Can Research · R01 · FY2020 · GM
The role of reorganization energy in achieving selective kinase inhibition
$352,465John Damon Chodera · Sloan-Kettering Inst Can Research · R01 · FY2019 · GM
REGULATION OF P93 C FES TYROSINE KINASE ACTIVITY
$352,463University Of Pittsburgh At Pittsburgh · R01 · FY2002 · CA
Reactive oxygen species and Genomic Instability in CML
$352,441Martin Sattler · Dana-Farber Cancer Inst · R01 · FY2011 · CA
Reactive oxygen species and Genomic Instability in CML
$352,441Martin Sattler · Dana-Farber Cancer Inst · R01 · FY2012 · CA
Bone Marrow Spatial Transcriptomics to Enhance In Vitro Platelet Production
$352,424Alan B. Cantor · Boston Children'S Hospital · R01 · FY2022 · HL
Bone Marrow Spatial Transcriptomics to Enhance In Vitro Platelet Production
$352,376Alan B. Cantor · Boston Children'S Hospital · R01 · FY2023 · HL
The Discovery of Human Peptide Encoding Genes
$352,374Alan Saghatelian · Harvard University · R01 · FY2013 · GM
DNA REPAIR DEFECT IN FANCONI ANEMIA, GROUP A
$352,356Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2000 · HL
Role of slug in hematopoietic stem cell regeneration
$352,350Wen-Shu Wu · Children'S Hospital & Res Ctr At Oakland · R01 · FY2011 · DK
Role of slug in hematopoietic stem cell regeneration
$352,350Wen-Shu Wu · Children'S Hospital & Res Ctr At Oakland · R01 · FY2012 · DK
A New Murine Model for MPN: Pathololgy and Therapy of NF-E2 Overexpression
$352,350Heike L Pahl · Icahn School Of Medicine At Mount Sinai · P01 · FY2011 · CA
Core A: Administration
$352,328Frederick R Appelbaum · Fred Hutchinson Cancer Center · P01 · FY2022 · CA
Dysregulated genome architecture in acute myeloid leukemia
$352,328David H Spencer · Washington University · R37 · FY2023 · CA
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
$352,327Carlo M Croce · Ohio State University · R01 · FY2013 · CA
Mechanism-based targeting of unique survival signaling in residual tumors
$352,309Kris C. Wood · Duke University · R01 · FY2025 · CA
Improving BTK Directed Therapy for CLL
$352,275Jennifer A. Woyach · Ohio State University · R01 · FY2016 · CA
Mechanisms of venetoclax combination activity in acute myeloid leukemia
$352,275Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2021 · CA
Overcoming Leukemia Chemoresistance in the Central Nervous System
$352,275Peter M Gordon · University Of Minnesota · R37 · FY2021 · CA
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
$352,275Michael A Caligiuri · Ohio State University · R01 · FY2015 · CA
Improving BTK Directed Therapy for CLL
$352,275Jennifer A. Woyach · Ohio State University · R01 · FY2017 · CA
Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention
$352,275Michael A Caligiuri · Ohio State University · R01 · FY2017 · CA
Biology and Targeting of noncoding RNAs in AML
$352,275Ramiro Garzon · Utah State Higher Education System--University Of Utah · R01 · FY2025 · CA
Targeting PTPN11 dependent Hematologic Malignancies
$352,275Bill H Chang · Oregon Health & Science University · R01 · FY2021 · CA
Overcoming Leukemia Chemoresistance in the Central Nervous System
$352,275Peter M Gordon · University Of Minnesota · R37 · FY2025 · CA